Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Increased risk of nonmelanoma skin cancer in patients with IBD who receive thiopurines.

Long MD.

Inflamm Bowel Dis. 2013 Jan;19(1):213-4. doi: 10.1002/ibd.22981. No abstract available.

PMID:
23292350
2.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group.

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
3.

Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.

Singh H, Nugent Z, Demers AA, Bernstein CN.

Gastroenterology. 2011 Nov;141(5):1612-20. doi: 10.1053/j.gastro.2011.07.039. Epub 2011 Jul 30.

PMID:
21806945
4.

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.

Setshedi M, Epstein D, Winter TA, Myer L, Watermeyer G, Hift R.

J Gastroenterol Hepatol. 2012 Feb;27(2):385-9. doi: 10.1111/j.1440-1746.2011.06865.x.

PMID:
21793904
5.

Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?

Beaugerie L.

Dig Dis. 2012;30(4):415-9. doi: 10.1159/000338144. Epub 2012 Jul 12. Review.

PMID:
22796808
6.

Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort.

Ashworth LA, Billett A, Mitchell P, Nuti F, Siegel C, Bousvaros A.

Inflamm Bowel Dis. 2012 May;18(5):838-43. doi: 10.1002/ibd.21844. Epub 2011 Sep 1.

PMID:
21887728
7.

The risk of developing subsequent nonmelanoma skin cancers.

Schreiber MM, Moon TE, Fox SH, Davidson J.

J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1114-8.

PMID:
2273111
8.

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.

van Schaik FD, van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B.

Gut. 2012 Feb;61(2):235-40. doi: 10.1136/gut.2011.237412. Epub 2011 May 20.

PMID:
21602529
9.

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB.

J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29.

10.

Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.

Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, Bavinck JN; Leiden Skin Cancer Study Team.

Am J Hum Genet. 2001 Apr;68(4):884-94. Epub 2001 Mar 16.

11.

Risk of nonmelanoma skin cancer with azathioprine use.

Maddox JS, Soltani K.

Inflamm Bowel Dis. 2008 Oct;14(10):1425-31. doi: 10.1002/ibd.20444. Review.

PMID:
18383175
12.

Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.

Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, Westendorp RG, ter Schegget J, Spaan WJ, Bouwes Bavinck JN.

Cancer Res. 2003 May 15;63(10):2695-700.

13.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.

Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2.

PMID:
23032984
14.

PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.

van Praag MC, Bavinck JN, Bergman W, Rosendaal FR, Mommaas AM, Bruynzeel I, Scheffer E, Vermeer BJ, Bruijn JA.

J Am Acad Dermatol. 1993 Mar;28(3):412-7.

PMID:
8445056
15.

Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81.

PMID:
14519754
16.

Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study.

Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, Schena D, Diociaiuti A, Nanni G, La Parola IL, Masini C, Piaserico S, Peserico A, Cainelli T, Remuzzi G.

Transplantation. 2000 Nov 27;70(10):1479-84.

PMID:
11118094
17.
18.
19.

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.

Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G, et al.

N Engl J Med. 1990 Sep 20;323(12):789-95. Erratum in: N Engl J Med 1991 Oct 31;325(18):1324.

20.

Sentinel lymph node biopsy in nonmelanoma skin cancer patients.

Matthey-Giè ML, Boubaker A, Letovanec I, Demartines N, Matter M.

J Skin Cancer. 2013;2013:267474. doi: 10.1155/2013/267474. Epub 2013 Feb 14.

Supplemental Content

Support Center